Sean Smith

Insider Reports History

Entity
Individual
Location
C/O Neoleukin Therapeutics, Inc., 188 E. Blaine Street, Suite 450, Seattle, WA
Signature
/s/ Sean Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Interim CFO, Prin Acct Off Common Stock 21.6K $15K $0.69 Aug 11, 2023 Direct
Neoleukin Therapeutics, Inc. Interim CFO, Prin Acct Off Restricted Stock Units 0 Aug 10, 2023 Direct

Insider Reports Filed by Sean Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLTX Neoleukin Therapeutics, Inc. Aug 10, 2023 3 -$818 4 Aug 14, 2023 Interim CFO, Prin Acct Off
NLTX Neoleukin Therapeutics, Inc. Feb 1, 2023 3 -$1.98K 4 Feb 3, 2023 Principal Accounting Officer
NLTX Neoleukin Therapeutics, Inc. Aug 10, 2022 3 -$1.64K 4 Aug 12, 2022 Principal Accounting Officer
NLTX Neoleukin Therapeutics, Inc. Aug 2, 2022 1 $0 4 Aug 4, 2022 Principal Accounting Officer
NLTX Neoleukin Therapeutics, Inc. Mar 2, 2022 1 $0 4 Mar 3, 2022 Principal Accounting Officer
NLTX Neoleukin Therapeutics, Inc. Mar 2, 2022 0 $0 3 Mar 3, 2022 Principal Accounting Officer